Valneva SE Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine

Valneva SE announced that the United Arab Emirates (UAE) granted emergency use authorization for Valneva's inactivated, adjuvanted COVID-19 vaccine, VLA2001. This authorization follows Conditional Marketing Authorization from the UK MHRA1, which was granted last month, and emergency use authorization from the Bahraini NHRA in March 2022.